ESTRO 2026
ESTRO 2025 focused on transformative innovation through partnership, via collaboration within our Radiation Oncology Community and especially with our scientific friends and partners from basic science, translational research and multidisciplinary cancer care. This journey will be continued, aiming to stay at the forefront of innovation. ESTRO 2026 will broach the opportunities to innovate our discipline itself, to optimally prepare us for tomorrow’s clinical, professional and scientific changes and challenges.
ESTRO 2026: Share proton therapy across national borders and plan five new centres in Romania, Greece, Italy, Northern Ireland and Poland to maximise access for patients in Europe
ESTRO 2026: Meeting an AI doctor before a real-life consultation improves cancer patients’ understanding and reduces stress
ESTRO 2026: Just two radiotherapy sessions given over eight days can treat prostate cancer without any extra side effects
ESTRO 2026: Breast cancer that has begun to spread could be controlled for longer with targeted radiotherapy
ESTRO 2026: AI tool for radiotherapy can support the global effort to eliminate cervical cancer
ESTRO 2026: Blood test that detects tumour DNA could help guide treatment when cancer has spread